In patients with advanced chronic kidney disease, does a 24‑hour urine test that does not include urinary aldosterone measurement give inaccurate results for confirming primary aldosteronism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

24-Hour Urine Testing Without Urinary Aldosterone in Advanced CKD: Inaccurate and Incomplete

In patients with advanced chronic kidney disease, performing a 24-hour urine test without measuring urinary aldosterone is fundamentally flawed and will yield inaccurate results for confirming primary aldosteronism—the urinary aldosterone measurement is the essential diagnostic component of this confirmatory test, not an optional add-on. 1

Why This Test Requires Urinary Aldosterone Measurement

The oral sodium suppression test (24-hour urine collection) specifically requires measurement of three components 1:

  • Urinary aldosterone (the primary diagnostic metric)
  • Urinary sodium (to confirm adequate sodium intake >200 mEq/24h)
  • Urinary creatinine (to verify collection adequacy)

Without urinary aldosterone measurement, you have no diagnostic information about primary aldosteronism—you're simply confirming sodium intake and collection adequacy without the actual test result. The interpretation threshold is 24-hour urinary aldosterone <10 mcg/24h (or <27.5 nmol/24h by LC-MS/MS) making PA unlikely 1, 2.

Special Considerations in Advanced CKD

The 2025 Endocrine Society guideline explicitly states that saline suppression testing (the intravenous alternative) should NOT be performed in patients with advanced chronic kidney disease due to high risk of pulmonary edema 1. This makes the oral sodium suppression test potentially more relevant in this population, but with important caveats:

CKD-Specific Diagnostic Challenges:

  • Renin decreases proportionately with nephron loss in CKD (except with renal artery stenosis) 1
  • Aldosterone can be elevated in CKD independently of PA, leading to increased false-positive screening results 1
  • These physiologic changes affect the aldosterone-renin ratio and make interpretation more complex

Alternative Confirmatory Tests in Advanced CKD:

Since saline infusion is contraindicated and oral sodium loading may have limitations, consider:

  1. Captopril challenge test (moderate quality evidence) 1:

    • Safer in CKD patients
    • Requires plasma aldosterone <277 pmol/L (10 ng/dL) by immunoassay or <203 pmol/L (7.5 ng/dL) by LC-MS/MS at 2 hours post-captopril with suppressed renin to exclude PA
    • Can be performed in-office with blood draws at baseline and 2 hours

  2. Proxy testing: Patients already on ACE inhibitors or ARBs may have aldosterone and renin values that serve as a proxy for captopril testing 1

Critical Pitfalls to Avoid

  • Never interpret a 24-hour urine collection without urinary aldosterone as a confirmatory test—it provides zero diagnostic information about PA
  • Do not use saline infusion testing in advanced CKD due to volume overload risk 1
  • Recognize that CKD itself causes renin suppression and aldosterone elevation, increasing false-positive rates during screening 1
  • Ensure potassium is normalized before any confirmatory testing, as hypokalemia causes false-negative results 1

Practical Algorithm for Advanced CKD Patients

  1. If screening suggests PA (elevated ARR with suppressed renin), recognize higher false-positive rates in CKD 1
  2. Avoid saline infusion test 1
  3. Choose captopril challenge test as the preferred confirmatory test in advanced CKD 1
  4. If oral sodium suppression is attempted, urinary aldosterone measurement is mandatory—without it, the test is invalid 1
  5. Consider that LC-MS/MS measurement of urinary aldosterone (cut-off ≥27.5 nmol/24h with urinary sodium ≥190 mmol/24h) provides superior specificity (92.3%) compared to immunoassay (77.8%) 2

The bottom line: A 24-hour urine test without urinary aldosterone measurement is not a confirmatory test for primary aldosteronism—it's an incomplete collection that cannot diagnose or exclude PA in any patient population, including those with advanced CKD.

References

1
Guideline

primary aldosteronism: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2025

2
Research

Urinary Aldosterone Analysed by LC-MS/MS vs Immunoassay for Diagnosis of Primary Aldosteronism.

The Journal of clinical endocrinology and metabolism, 2026

Related Questions

According to the 2025–2026 Endocrine Society primary aldosteronism guidelines, is a 24‑hour urine aldosterone measurement required as a confirmatory test after a positive aldosterone‑to‑renin ratio screen?
In patients with a positive aldosterone-to-renin ratio (ARR) screened for primary aldosteronism, which patients should undergo confirmatory testing such as a 24‑hour urine collection for aldosterone, sodium, and creatinine?
In a hypokalemic patient receiving potassium chloride, should we obtain plasma aldosterone concentration and plasma renin activity before stopping supplementation to evaluate for primary aldosteronism?
Given a plasma renin activity of 0.12 ng/mL/h, an aldosterone‑to‑renin ratio of 66.7, and an aldosterone level of 8 ng/dL, what is the most likely diagnosis and what are the appropriate next diagnostic and treatment steps?
What is the confirmatory diagnostic test for central (secondary) adrenal insufficiency?
What is the appropriate evaluation for amenorrhea?
Why does mottling occur in acute limb ischemia?
In a patient with hand swelling and a normal complete blood count, what does an anti‑cyclic citrullinated peptide (anti‑CCP) antibody test show?
What is the appropriate renal dosing of amoxil (amoxicillin) for treating community‑acquired pneumonia?
Can I administer Geodon (ziprasidone) orally and intramuscularly for agitation?
Are there any vaccines that should not be administered concurrently with the seasonal influenza vaccine?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.